Results
The study cohort included 1982 patients median age 74 years, of which
136 (7%) experienced ≥1 adverse medication event(s). The model
included: length of stay, hospital re-admission within 12 months, venous
or arterial thrombosis &/or embolism, ≥ 8 medications, serum sodium
< 126 mmol/L, INR > 3, anti-psychotic,
antiarrhythmic and immunosuppressant medications, and history of
medication allergy. Validation gave an AuROC of 0.70 (95% CI:
0.65-0.74). Decision curve analysis identified that the AIME may be
clinically useful to help guide decision making in practice.